from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3565/aspB

LFCtreatmentdescriptionclass of inhibitor

0.084

Amikacinug/mL Amikacintranslation

-0.254

Cap5-10ug/mL Capreomycintranslation

0.237

Rox10-50 ug/mL Roxithromycintranslation

0.651

SM2-5 ug/mL Streptomycintranslation

2.148

Tet5-10 ug/mL Tetracyclinetranslation

0.505

Rif0.2-5ug/mL Rifampicintranscription

0.464

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.933

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.398

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.625

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.556

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.435

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.222

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.014

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.819

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.226

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.117

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.032

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.009

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.818

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.009

Nigericin50 uM Nigericinrespiration

0.214

TRC10-150 ug/mL Triclosanrespiration

-0.734

TRZ10-25 ug/mL Thioridazinerespiration

-0.904

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.476

menadione6-10 ug/mL Menadionerespiration

0.312

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.125

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.672

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.564

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.568

NRP_1Non-replicating persistence stage 1dosRassociated

-0.285

Amp0.2mg/mL AmpicillincellWall

0.202

Cephalexin20-100 ug/mL CephalexincellWall

0.848

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.525

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-1.251

EMB10-20 ug/mL EthambutolcellWall

0.631

Eta12-40 ug/mL EthionamidecellWall

-0.186

INH0.2-0.4 ug/mL IsoniazidcellWall

0.612

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.514

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.080

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.239

BZA0.12 mg/mL BenzamidearomaticAmides

0.157

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.109

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.045

H2O24 mM hydrogen peroxideDNAdamaging

-0.112

Levo10 ug/mL LevofloxacinDNAdamaging

-0.146

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.078

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.081

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.267

UVUV-irradiationDNAdamaging

-0.636

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.703

Antimycin12.5-50 ug/mL Antimycin A?

-0.924

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.496

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.417

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.833

PA8240.2-2 ug/mL PA-824?

0.057

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.094

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.271

Verapamil50 uM Verapamil?

-0.955

mercaptoethanol2 mM 2-Mercaptoethanol?

0.207

methoxatin10-20 ug/mL Methoxatin?